Ondansetrone Hikma

Ondansetron, the active ingredient in Ondansetrone Hikma, is a serotonin 5‑HT3 receptor antagonist presented as a tablet for oral use. It is used to prevent nausea and vomiting caused by chemotherapy, radiation therapy, and surgery in adult and pediatric patients.

GNH USA supplies Ondansetrone Hikma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ondansetron is employed across several clinical pathways that involve nausea and vomiting control. - Chemotherapy‑induced nausea and vomiting (CINV): helps reduce the frequency and severity of nausea and vomiting associated with cancer‑directed chemotherapy. - Radiation‑induced nausea and vomiting (RINV): lessens nausea and vomiting that occur during or after radiation treatment. - Post‑operative nausea and vomiting (PONV): decreases the incidence of nausea and vomiting after surgical procedures. - Pregnancy‑related nausea (hyperemesis gravidarum): provides symptomatic relief for severe nausea and vomiting during pregnancy.

Side effects of ondansetron are generally mild but can vary in frequency.

Common Side Effects: - Headache: mild to moderate intensity. - Constipation: reduced bowel movements. - Diarrhoea: loose stools. - Fatigue: feeling of tiredness. - Dizziness: light‑headed sensation.

Serious or Rare Side Effects: - Cardiac arrhythmia: irregular heart rhythm, including QT prolongation. - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Serotonin syndrome: agitation, confusion, rapid heart rate, and high blood pressure. - Hepatic dysfunction: elevated liver enzymes indicating liver stress.

When using ondansetron, consider the following safety measures: - Cardiac monitoring: patients with known QT prolongation or electrolyte imbalance should be monitored. - Electrolyte balance: correct potassium, magnesium, and calcium levels before administration. - Concomitant medications: review other drugs that may affect cardiac rhythm. - Pregnancy: use only if clearly needed, as safety data are limited. - Breastfeeding: assess risk‑benefit before use. - Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Ondansetron may interact with several medicines, requiring attention to the interaction severity.

Major Interactions (Avoid): - Apomorphine: may cause profound hypotension and loss of consciousness. - Certain anti‑arrhythmic drugs (e.g., amiodarone, quinidine) that prolong QT interval.

Moderate Interactions (Monitor Closly): - Other serotonergic agents (e.g., SSRIs, SNRIs, tramadol) – risk of serotonin syndrome. - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin) – may increase ondansetron levels. - CYP2D6 inhibitors (e.g., fluoxetine, paroxetine) – may raise plasma concentrations. - Digoxin: may increase serum digoxin concentrations.